Loading clinical trials...
Loading clinical trials...
An Open Label Study to Investigate the Safety and Efficacy of Abacavir/Lamivudine/Dolutegravir and the Pharmacokinetic Profile of Dolutegravir in HIV-infected Patients of 60 Years of Age and Older
Conditions
Interventions
Triumeq
Locations
1
United Kingdom
St Stephen's Centre, Chelsea & Westminster Hospital
London, United Kingdom
Start Date
August 4, 2015
Primary Completion Date
February 13, 2017
Completion Date
July 24, 2017
Last Updated
February 28, 2018
NCT07071623
NCT04929028
NCT01875588
NCT03087253
NCT07199335
NCT05419024
Lead Sponsor
St Stephens Aids Trust
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions